1. Combined evaluation of proliferation and apoptosis to calculate IC50 of VPA-induced PANC-1 cells and assessing its effect on the Wnt signaling pathway
   Yeliz Ekici et al, 2021, Medical Oncology CrossRef
2. The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation
   Amber Blaauboer et al, 2022, Biomedicines CrossRef
3. The Immune Microenvironment in Pancreatic Cancer
   Magdalena Huber et al, 2020, International Journal of Molecular Sciences CrossRef
4. NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy
   Dominik Schmiedel et al, 2018, Frontiers in Immunology CrossRef
5. Leveraging NKG2D Ligands in Immuno-Oncology
   Mercedes Beatriz Fuertes et al, 2021, Frontiers in Immunology CrossRef
6. Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors.
   null Roca et al, 2019, Journal of Clinical Medicine CrossRef